|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S1
|
$48,687
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S2
|
$85,299
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-09
|
$714,423
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
|
1R01CA231283-01
|
$501,220
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-03
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
5R01CA219880-02
|
$670,182
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
|
1R01CA231112-01
|
$576,627
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
5R01CA208735-02
|
$730,063
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-09
|
$1,304,869
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
|
1P20CA233355-01
|
$255,958
|
VISHWANATHA, JAMBOOR
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-09
|
$1,003,901
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-13
|
$1,101,004
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-13
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A 3D Model of the Perivascular Niche to Investigate Glioblastoma Invasion
|
1F31CA228317-01
|
$39,703
|
WOLF, KAYLA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC
|
1R21CA229927-01
|
$218,588
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
7R21CA208618-02
|
$176,380
|
INTINI, GIUSEPPE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
|
1R01CA222802-01A1
|
$412,139
|
LAW, BENEDICT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
|
1R44CA224835-01A1
|
$298,864
|
PERICLE, FEDERICA
|
AGILVAX, INC.
|
|
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma
|
1R43CA221389-01A1
|
$224,919
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
|
4R44CA217591-02
|
$1,125,311
|
KAHN, STUART
|
SYNTRIX BIOSYSTEMS, INC.
|
|
A Quality Control Program for Quantitative MRI Data Acquisition and Analysis in Multi-site Clinical Trials
|
1R44CA235820-01
|
$224,422
|
KARAULANOV, TODOR
|
QALIBREMD, INC.
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S1
|
$244,519
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$813,241
|
Hofmann, Jonathan
|
DCEG (NCI)
|
|
An organotypic model recapitulating colon cancer microenvironment and metastasis
|
5U01CA214300-02
|
$673,627
|
HUANG, EMINA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
2R44CA200161-02A1
|
$1,000,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S3
|
$3,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$3,223,418
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Black/White PHS Study
|
ZIA CP010136 00430
|
$43,221
|
Silverman, Debra
|
DCEG (NCI)
|
|
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
|
1R44CA228694-01
|
$300,000
|
SILBERSTEIN, DAVID
|
BIOMIMETIX JV, LLC
|
|
Breaking the Obesity-Cancer Link: New Targets and Strategies
|
3R35CA197627-04S1
|
$82,611
|
HURSTING, STEPHEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Breaking the Obesity-Cancer Link: New Targets and Strategies
|
5R35CA197627-04
|
$762,608
|
HURSTING, STEPHEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
3R01CA177069-05S1
|
$75,000
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer and Health Outcomes Study
|
ZIA CP010226 10686
|
$323,191
|
Hoover, Robert
|
DCEG (NCI)
|
|
Cancer and Stem Cell Dynamics in the Intestine
|
5R00CA181679-04
|
$248,992
|
FISCHER, JARED
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-33S1
|
$150,000
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
5P30CA034196-33
|
$2,100,000
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-47
|
$3,572,644
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|